Aims Mineralocorticoid receptor (MR) antagonists improve cardiovascular outcomes in patients with heart failure complicating acute myocardial infarction (AMI) and in chronic heart failure. It is ...

Aldosterone acts as a mediator of hypertension, heart failure and kidney disease, and aldosterone synthase inhibitors (ASIs) have emerged as an alternative approach for the treatment of some of these ...

Current treatment options for primary aldosteronism are limited to surgery or mineralocorticoid receptor antagonists when surgery isn't an option. In a phase IIa trial, baxdrostat resolved or reduced ...

Please provide your email address to receive an email when new articles are posted on . An updated clinical practice guideline suggested screening all people with hypertension for primary ...